KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2024)

Historic Other Operating Expenses for Bionano Genomics (BNGO) over the last 5 years, with Q4 2024 value amounting to $138000.0.

  • Bionano Genomics' Other Operating Expenses fell 8137.65% to $138000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $138000.0, marking a year-over-year decrease of 9951.25%. This contributed to the annual value of $27.7 million for FY2024, which is 6449.03% down from last year.
  • Latest data reveals that Bionano Genomics reported Other Operating Expenses of $138000.0 as of Q4 2024, which was down 8137.65% from $21.3 million recorded in Q3 2024.
  • Over the past 5 years, Bionano Genomics' Other Operating Expenses peaked at $77.3 million during Q3 2023, and registered a low of $138000.0 during Q4 2024.